That would be nice. I'm trying to keep my expec
Post# of 148288
I'm trying to keep my expectations tempered, as I have allowed myself to get excited in the past.
But, I am really looking forward to seeing if we were able to demonstrate efficacy in LH.
If we do, and assuming we can design a solid P3 trial, I believe this will begin to support the share price. Particularly if we repeat the rapid enrollment of P2.